Multi-scale Iterative Refinement towards Robust and Versatile Molecular Docking

Molecular docking is a key computational tool utilized to predict the binding conformations of small molecules to protein targets, which is fundamental in the design of novel drugs. Despite recent advancements in geometric deep learning-based approaches leading to improvements in blind docking efficiency, these methods have encountered notable challenges, such as limited generalization performance on unseen proteins, the inability to concurrently address the settings of blind docking and site-specific docking, and the frequent occurrence of physical implausibilities such as inter-molecular steric clash. In this study, we introduce DeltaDock, a robust and versatile framework designed for efficient molecular docking to overcome these challenges. DeltaDock operates in a two-step process: rapid initial complex structures sampling followed by multi-scale iterative refinement of the initial structures. In the initial stage, to sample accurate structures with high efficiency, we develop a ligand-dependent binding site prediction model founded on large protein models and graph neural networks. This model is then paired with GPU-accelerated sampling algorithms. The sampled structures are updated using a multi-scale iterative refinement module that captures both protein-ligand atom-atom interactions and residue-atom interactions in the following stage. Distinct from previous geometric deep learning methods that are conditioned on the blind docking setting, DeltaDock demonstrates superior performance in both blind docking and site-specific docking settings. Comprehensive experimental results reveal that DeltaDock consistently surpasses baseline methods in terms of docking accuracy. Furthermore, it displays remarkable generalization capabilities and proficiency for predicting physically valid structures, thereby attesting to its robustness and reliability in various scenarios.

A Systematic Survey in Geometric Deep Learning for Structure-based Drug Design

Structure-based drug design (SBDD), which utilizes the three-dimensional geometry of proteins to identify potential drug candidates, is becoming increasingly vital in drug discovery. However, traditional methods based on physiochemical modeling and experts' domain knowledge are time-consuming and laborious. The recent advancements in geometric deep learning, which integrates and processes 3D geometric data, coupled with the availability of accurate protein 3D structure predictions from tools like AlphaFold, have significantly propelled progress in structure-based drug design. In this paper, we systematically review the recent progress of geometric deep learning for structure-based drug design. We start with a brief discussion of the mainstream tasks in structure-based drug design, commonly used 3D protein representations and representative predictive/generative models. Then we delve into detailed reviews for each task (binding site prediction, binding pose generation, \emph{de novo} molecule generation, linker design, and binding affinity prediction), including the problem setup, representative methods, datasets, and evaluation metrics. Finally, we conclude this survey with the current challenges and highlight potential opportunities of geometric deep learning for structure-based drug design.We curate a GitHub repo containing the related papers \url{https://github.com/zaixizhang/Awesome-SBDD}.

Multi-task Bioassay Pre-training for Protein-ligand Binding Affinity Prediction

Protein-ligand binding affinity (PLBA) prediction is the fundamental task in drug discovery. Recently, various deep learning-based models predict binding affinity by incorporating the three-dimensional structure of protein-ligand complexes as input and achieving astounding progress. However, due to the scarcity of high-quality training data, the generalization ability of current models is still limited. In addition, different bioassays use varying affinity measurement labels (i.e., IC50, Ki, Kd), and different experimental conditions inevitably introduce systematic noise, which poses a significant challenge to constructing high-precision affinity prediction models. To address these issues, we (1) propose Multi-task Bioassay Pre-training (MBP), a pre-training framework for structure-based PLBA prediction; (2) construct a pre-training dataset called ChEMBL-Dock with more than 300k experimentally measured affinity labels and about 2.8M docked three-dimensional structures. By introducing multi-task pre-training to treat the prediction of different affinity labels as different tasks and classifying relative rankings between samples from the same bioassay, MBP learns robust and transferrable structural knowledge from our new ChEMBL-Dock dataset with varied and noisy labels. Experiments substantiate the capability of MBP as a general framework that can improve and be tailored to mainstream structure-based PLBA prediction tasks. To the best of our knowledge, MBP is the first affinity pre-training model and shows great potential for future development.